Mixing specific ingredients with probiotics makes good sense in a market where consumer health and wellbeing are pillars.
“Once again, we will have our US team in place when the doors open to the SupplySide West trade show on November 7,” says Chr. Hansen’s Charlotte Beyerholm, Marketing Director, Human Health & Nutrition Division. “In particular, we are looking forward to discussing the properties of our latest probiotic innovations with our US customers.
“We have built a knowledge and technological platform investigating different ingredients as possible combination ingredients with our documented probiotic strains.
When developing the combo concept we looked into important parameters such as health area and compatibility of the selected ingredients.
New probiotic product samples
“Our new probiotic chewable tablet combines Lactobacillus L. casei 431® and vitamin C and is an ideal "dual action" combination for immune support,” Charlotte Beyerholm explains.
Another example is a powder stick containing Chr. Hansen’s probiotic strain LGG® and Oral Rehydration Solution (ORS), which are solutions of salts and sugar. The new triple action product has been developed to tackle diarrhea by
• shortening the duration
• preventing dehydration or speeding up recovery
• providing support to restore the intestinal flora
The convenient product is simply dissolved in 200 ml of cold water and unlike most ORS products, it has a nice, sweet taste.
Chr. Hansen at SupplySide West 2012
Chr. Hansen’s probiotic experts will be in place at the SupplySide West 2012 trade show on November 7-8 (booth # 19012), ready to discuss the business opportunities of visitors and share their knowledge about the probiotic market and consumer preferences.
On November 9, Chr. Hansen is sponsoring the probiotic workshop, organized by the International Probiotics Association (IPA).
Further information on our webpage
Click here for more information about Chr. Hansen’s probiotics
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.